Chen Y - Search Results

1

Minor Changes in Expression of the Mismatch Repair Protein MSH2 Exert a Major Impact on Glioblastoma Response to Temozolomide.

McFaline-Figueroa JL, Braun CJ, Stanciu M, Nagel ZD, Mazzucato P, Sangaraju D, Cerniauskas E, Barford K, Vargas A, Chen Y, Tretyakova N, Lees JA, Hemann MT, White FM, Samson LD. McFaline-Figueroa JL, et al. Among authors: chen y. Cancer Res. 2015 Aug 1;75(15):3127-38. doi: 10.1158/0008-5472.CAN-14-3616. Epub 2015 May 29. Cancer Res. 2015. PMID: 26025730 Free PMC article.

2

P-glycoprotein expression and schedule dependence of adriamycin cytotoxicity in human colon carcinoma cell lines.

Lai GM, Chen YN, Mickley LA, Fojo AT, Bates SE. Lai GM, et al. Among authors: chen yn. Int J Cancer. 1991 Nov 11;49(5):696-703. doi: 10.1002/ijc.2910490512. Int J Cancer. 1991. PMID: 1682280

3

beta-cyclodextrin tetradecasulfate/tetrahydrocortisol +/- minocycline as modulators of cancer therapies in vitro and in vivo against primary and metastatic Lewis lung carcinoma.

Teicher BA, Sotomayor EA, Huang ZD, Ara G, Holden S, Khandekar V, Chen YN. Teicher BA, et al. Among authors: chen yn. Cancer Chemother Pharmacol. 1993;33(3):229-38. doi: 10.1007/BF00686221. Cancer Chemother Pharmacol. 1993. PMID: 8269604

4

Interaction of interleukin-11 with cytotoxic therapies in vitro against CEM cells and in vivo against EMT-6 murine mammary carcinoma.

Teicher BA, Chen YN, Ara G, Emi Y, Kakeji Y, Maehara Y, Keyes S, Northey D. Teicher BA, et al. Among authors: chen yn. Int J Cancer. 1996 Sep 17;67(6):864-70. doi: 10.1002/(SICI)1097-0215(19960917)67:6<864::AID-IJC17>3.0.CO;2-1. Int J Cancer. 1996. PMID: 8824560 Free article.

5

Characterization of adriamycin-resistant human breast cancer cells which display overexpression of a novel resistance-related membrane protein.

Chen YN, Mickley LA, Schwartz AM, Acton EM, Hwang JL, Fojo AT. Chen YN, et al. J Biol Chem. 1990 Jun 15;265(17):10073-80. J Biol Chem. 1990. PMID: 1972154 Free article.

6

Potentiation of cytotoxic cancer therapies by TNP-470 alone and with other anti-angiogenic agents.

Teicher BA, Holden SA, Ara G, Sotomayor EA, Huang ZD, Chen YN, Brem H. Teicher BA, et al. Among authors: chen yn. Int J Cancer. 1994 Jun 15;57(6):920-5. doi: 10.1002/ijc.2910570624. Int J Cancer. 1994. PMID: 7515861

7

Synthesis and potent antifolate activity and cytotoxicity of B-ring deaza analogues of the nonpolyglutamatable dihydrofolate reductase inhibitor Nalpha-(4-amino-4-deoxypteroyl)-Ndelta-hemiphthaloyl- L-ornithine (PT523).

Rosowsky A, Wright JE, Vaidya CM, Bader H, Forsch RA, Mota CE, Pardo J, Chen CS, Chen YN. Rosowsky A, et al. Among authors: chen cs, chen yn. J Med Chem. 1998 Dec 17;41(26):5310-9. doi: 10.1021/jm980477+. J Med Chem. 1998. PMID: 9857098

8

CAI: effects on cytotoxic therapies in vitro and in vivo.

Teicher BA, Holden SA, Chen YN, Ara G, Korbut TT, Northey D. Teicher BA, et al. Among authors: chen yn. Cancer Chemother Pharmacol. 1994;34(6):515-21. doi: 10.1007/BF00685664. Cancer Chemother Pharmacol. 1994. PMID: 7923563

9

Expression of a drug resistance gene in human neuroblastoma cell lines: modulation by retinoic acid-induced differentiation.

Bates SE, Mickley LA, Chen YN, Richert N, Rudick J, Biedler JL, Fojo AT. Bates SE, et al. Among authors: chen yn. Mol Cell Biol. 1989 Oct;9(10):4337-44. doi: 10.1128/mcb.9.10.4337-4344.1989. Mol Cell Biol. 1989. PMID: 2573830 Free PMC article.

10

Mendelian randomization evidence based on European ancestry for the causal effects of leukocyte telomere length on prostate cancer.

Wu X, Hu C, Wu T, Du X, Peng Z, Xue W, Chen Y, Dong L. Wu X, et al. Among authors: chen y. Hum Genomics. 2024 Jun 3;18(1):56. doi: 10.1186/s40246-024-00622-8. Hum Genomics. 2024. PMID: 38831447

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

166,476 results

Search Page